Fungal Pathogens III Flashcards
Fungal resistance is not as big a problem as antibiotic resistance because
Fungi do not have horizontal gene transfer
Types of antifungal agents
- Membrane disrupting agents (polyenes)
- Ergosterol synthesis inhibitors (azoles, allylamines)
- DNA synthesis inhibitors (flucytosine)
- Glucan synthesis inhibitors (echinocandins)
Why are there so few antifungals?
- Fungi are eukaryotes so closely related to our cells
2. Antifungals are very difficult to get into fungi (cell wall and efflux pumps)
Polyenes
Membrane disrupting agents
Associate with ergosterol to form pores
Leak cations Na and Ca
Nystatin and Amphotericin B
Ergosterol is the fungal equivalent of
Cholesterol
Polyenes can be toxic due to them binding to
Human cholesterol
Ergosterol and cholesterol structures very similar
Nystatin is used for
Superficial infections
Amphotericin B is used for
Systemic infections
Amphotericin B problems
IV use only
Nephrotoxicity (kidneys)
Polyenes have
A wide spectrum
Candida, cryptococcus, aspergillus
Azoles are the
Largest group of antifungals (5)
Azole refers to the
5 membered heterocyclic ring (Nitrogens)
Imidazole has
2 N, rarely used, toxic
Triazole has
3 N, commonly used
Azoles inhibit
Ergosterol synthesis
Azoles block the
14 alpha sterol demethylase (enzyme that demethylates lanosterol)
Blocks haem iron in the enzyme
Alters membrane fluidity (rigid)as alpha sterols build up
FUNGISTATIC - blocks growth but does not kill them
Azoles stop the demethylation of
Lanosterol
14 alpha sterol demethylase demethylates
Lanosterol
Azoles have a
Broad spectrum
Except - fluconazole, does not work on aspergillus
Azoles are mainly
Fungistatic
Azoles problems
- Drug interactions:
- target enzyme related to cytochrome P450
- can block human P450 in the liver so affect drug metabolism of other drugs - Resistance
Allylamines inhibit
Ergosterol biosynthesis - squalene epoxidase
Allylamines cause cells to
Accumulate squalene which is toxic
Accumulation of squalene is
Fungicidal
Allylamines are most effective against
Dermatophytes
limited use in candida, aspergillus and cryptococcus
5 flucytosine (5FC) is a
Synthetic analogue of cytosine
5FC enters cells through
Cytosine permease (enzyme in cell wall)
5FC is converted by cytosine deaminase to
5 Fluoroucil (5FU)
5FC inhibits
Protein and DNA synthesis
5FU gets incorporated into
mRNA
The ribosome cannot read it
5FC only works against
Yeasts
Candida and cryptococcus
(filamentous fungi lack cytosine permease and cytosine deaminase)
5FC problems
Resistance is very common
Not used as a single agent and never in candida
Echinocandins are
Semi synthetic (developed in 2000’s)
Echinocandins inhibit
Beta 1,3 glucan synthase
essential component of cell wall
Echinocandins can be either fungistatic or fungicidal
Fungicidal in candida
Fungistatic in aspergillus
Not effective in cryptococcus
Echinocandins good things
No problem of cross resistance
Low toxicity
Echinocandins problems
Not effective against cryptococcus
IV use only
Expensive
Treating superficial infections
Dermatophytes - allylamines
Candida - Azoles
Treating systemic infections
Azoles
Amphotericin B (IV)
Echinocandins (IV)
Mechanisms of resistance
- Primary/Natural
2. Secondary/Aquired
Primary/Natural resistance
Intrinsic resistance linked to species or strain
(Allylamines not effective against candida)
(Fluconazole intrinsically not effective against cryptococcus)
Secondary/Aquired resistance
Susceptible strain becomes resistant
Mutation and selection
Resistance to Amphotericin B is
Rare
Mechanism of Amp B resistance
- Reduced/alteration of ergosterol content
- Alteration of sterol/phospholipid balance
- Increased catalase activity (combat oxidative stress associated with amphotericin exposure)
Resistance to Flucytosine
Primary ( ALL filamentous fungi)
(10% of candida)
Secondary (monotherapy, 30% candida resistant after treatment)
Flucytosine mechanism of resistance
- Loss of permease activity
- Loss of cytosine deaminase activity
- Decrease in the activity of uracil phosphoribosyl-transferase
Partial resistance to 5FU is achieved through blocking action in mRNA
Mutations
Resistance to Echinocandins
Primary - cryptococcus
Secondary - rare
Echinocandin mechanism of resistance
Point mutations in beta 1,3 glucan synthase
Upregulated chitin synthesis
Resistance to azoles
Primary - aspergillus, cryptococcus
Secondary - candida, common in HIV
Azole resistance mechanism
- Reduced accumulation of azole (overexpression of efflux pumps)
- Alteration of target enzyme (point mutations decrease affinity of azole)
- Upregulate ERG11 (need more drug to compete)
- Alterations in sterol synthesis - blocking methylation (causes dual resistance to azoles and polyenes)
ERG11
Ergosterol biosynthesis
Mechanisms of resistance can be
Cumulative/additive
The 4 classes of antifungal agents
- Azoles
- Polyenes
- Echinocandins
- Flucytosine
Limitations of antifungals
Interactions
Toxicity
Resistance
Cost and availability
Resistance is common with
Flucytosine
Resistance is rare with
Azoles, polyenes, echinocandins